Evidence map›Paper›PMID 42014517›Full record

ReviewCurrent pain and headache reports2026

The Connections Between Pain and Itch: Shared Neuroimmune Mechanisms and Therapeutic Implications.

Alaa Abd-Elsayed, Marco Troka, Jaemin Kim, Robert Moghim, Alan David Kaye, Madelyn Reilly

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alaa Abd-ElsayedDepartment of Anesthesiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, B6/319 CSC, Madison, WI, 53792-3272, USA. alaaawny@hotmail.com.ORCID http://orcid.org/0000-0002-9890-7860
Marco TrokaDepartment of Anesthesiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, B6/319 CSC, Madison, WI, 53792-3272, USA.ORCID http://orcid.org/0009-0000-9305-9439
Jaemin KimDepartment of Anesthesiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, B6/319 CSC, Madison, WI, 53792-3272, USA.
Robert MoghimInterventional Pain & Spine, Colorado Pain Care, 2696 S Colorado Blvd #240, Denver, CO, 80222, USA.
Alan David KayeDepartment of Anesthesiology, Louisiana State University School of Medicine, 1501 Kings Highway, Shreveport, LA, 71103, USA.
Madelyn ReillyDepartment of Anesthesiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, B6/319 CSC, Madison, WI, 53792-3272, USA.ORCID http://orcid.org/0009-0005-8828-7740

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewPain and itch are distinct somatosensory modalities with essential protective functions, yet they exhibit substantial neurobiological and clinical overlap. Although traditionally considered separate sensory systems, accumulating evidence indicates that nociception and pruritus are mediated and modulated by interacting neuronal populations, shared signaling pathways, and common inflammatory mechanisms. This review aims to synthesize current understanding of the convergent peripheral and central processes underlying pain and itch and to highlight their implications for diagnosis and treatment. RECENT

findingsRecent advances have identified overlapping molecular and cellular substrates involved in pain and itch processing, including transient receptor potential (TRP) channels, G-protein–coupled receptors (GPCRs), and neuroimmune signaling mediated by cytokines, mast cells, and glial activation. At the spinal level, inhibitory gating mechanisms that suppress itch in response to noxious stimuli have been elucidated, as well as maladaptive plasticity contributing to central sensitization in chronic pain and chronic pruritus states. Clinically, these shared mechanisms manifest across diverse conditions, including neuropathic disorders, dermatologic diseases, and systemic illnesses, complicating phenotypic differentiation between pain-dominant and itch-dominant presentations. Therapeutic strategies increasingly target overlapping pathways, encompassing gabapentinoids, opioid-modulating agents, biologic therapies, and emerging gene-silencing approaches. Pain and itch represent interconnected sensory experiences supported by shared neurobiological substrates rather than fully independent systems. Integrating mechanistic insights with clinical phenotyping provides a unified framework for understanding these modalities and highlights opportunities for mechanism-based, cross-modal therapeutic strategies. Such an approach may improve diagnostic accuracy and optimize treatment outcomes for complex sensory disorders characterized by overlapping pain and itch phenotypes.

Indexed as

NeuroimmunomodulationPainPruritusAnimalsHumansNociceptionCentral sensitizationItchNeuroimmune interactionsNociceptionPainPruritus

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.